Rothschild Investment LLC’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.39K Buy
189
+19
+11% +$414 ﹤0.01% 2228
2026
Q1
$2.95K Buy
170
+39
+30% +$738 ﹤0.01% 2350
2025
Q4
$2.47K Buy
131
+26
+25% +$436 ﹤0.01% 2261
2025
Q3
$1.53K Sell
105
-25
-19% -$356 ﹤0.01% 2390
2025
Q2
$2.54K Buy
130
+50
+63% +$888 ﹤0.01% 1896
2025
Q1
$1.42K Buy
80
+15
+23% +$323 ﹤0.01% 2115
2024
Q4
$1.39K Hold
65
﹤0.01% 2023
2024
Q3
$2.03K Buy
65
+40
+160% +$995 ﹤0.01% 1720
2024
Q2
$388 Buy
+25
New +$302 ﹤0.01% 2174

Other funds holding CDNA

Rothschild Investment LLC's CDNA Position: Q2 2026 in Review

Rothschild Investment LLC increased its CareDx (CDNA) stake by 11% in Q2 2026, buying an estimated $414 and bringing the position to 189 shares worth $5.39K. The position accounts for ﹤0.01% of the portfolio, ranked #2228.

Rothschild Investment LLC first reported a position in CDNA in Q2 2024 and has held it in 9 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Rothschild Investment LLC held 189 shares of CareDx worth $5.39K as of Q2 2026.
  • Rothschild Investment LLC bought 19 CareDx shares in Q2 2026, an estimated $414.
  • CareDx made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2228 holding.
  • Rothschild Investment LLC first reported a position in CareDx in Q2 2024 and has held it in 9 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.